Wellgistics Health, Inc. (NASDAQ:MEDS) Short Interest Update

Wellgistics Health, Inc. (NASDAQ:MEDS) was the recipient of a significant growth in short interest in September. As of September 15th, there was short interest totaling 430,628 shares, a growth of 147.5% from the August 31st total of 173,986 shares. Based on an average trading volume of 6,603,130 shares, the days-to-cover ratio is currently 0.1 days. Approximately 19.0% of the company’s stock are short sold.

Wellgistics Health Stock Down 11.1%

Shares of NASDAQ MEDS traded down $0.39 during trading on Friday, reaching $3.11. 408,549 shares of the company traded hands, compared to its average volume of 14,568,824. The firm has a 50 day simple moving average of $2.78 and a 200-day simple moving average of $4.16. Wellgistics Health has a 52-week low of $0.82 and a 52-week high of $73.00. The stock has a market capitalization of $9.95 million, a PE ratio of -0.07 and a beta of -1.77.

Wellgistics Health (NASDAQ:MEDS) last posted its earnings results on Monday, August 17th. The company reported ($7.13) EPS for the quarter. The business had revenue of $1.78 million for the quarter.

Analyst Ratings Changes

Several analysts recently commented on MEDS shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a research report on Monday, September 21st. Wall Street Zen raised shares of Wellgistics Health from a “strong sell” rating to a “sell” rating in a report on Saturday, July 4th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Wellgistics Health Company Profile

Wellgistics Health, Inc (NASDAQ:MEDS) is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medicines. The company provides infrastructure designed to connect healthcare providers, pharmacies, pharmaceutical manufacturers and patients within the prescription-drug supply chain.

Its business activities include pharmaceutical distribution and technology-enabled services intended to support medication ordering, fulfillment and delivery.